Ho Tae Nam

Title: Innovations by Inventor Ho Tae Nam

Introduction

Ho Tae Nam is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dry eye syndrome and gastric conditions. With a total of 2 patents, his work showcases innovative approaches to common health issues.

Latest Patents

One of his latest patents is an oral pharmaceutical composition for preventing or treating dry eye syndrome, which comprises rebamipide or a prodrug thereof. This composition offers a safer and more convenient alternative to conventional eye drops. Another significant patent involves a novel rebamipide prodrug, which has an increased absorption rate of 25-fold compared to rebamipide itself. This prodrug can be utilized in the treatment of various conditions, including gastric ulcers, acute gastritis, chronic gastritis, xerophthalmia, cancer, osteoarthritis, rheumatoid arthritis, and obesity.

Career Highlights

Ho Tae Nam has worked with reputable companies such as Samjin Pharmaceutical Co., Ltd. and Astech Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Throughout his career, he has collaborated with notable coworkers, including Eui Hwan Cho and Sung Ju Choi. These partnerships have likely enhanced his research and development efforts.

Conclusion

Ho Tae Nam's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through inventive solutions. His patents reflect a deep understanding of medical needs and a drive to create effective treatments.